Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal

NCT03064035 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

79

Enrollment

OTHER

Sponsor class

Conditions

Acute Bleeding on Long-Term Anticoagulation Therapy
Hemorrhage
Significant Bleeding in Patients With a Coagulopathy (Prolonged Thrombin Time)
Urgent Reversal of Vitamin K Antagonist (VKA) Anticoagulation

Interventions

DRUG: 4-factor prothrombin complex concentrate (4FPCC)

Sponsor

HealthPartners Institute